Showing results (31-40 of 59) with videos related to

Sort By:
Pageof 6
American Journal of Hematology|April 4, 2017
Long term impact of hyperleukocytosis in newly diagnosed acute myeloid leukemia patients undergoing allogeneic stem cell transplantation: An analysis from the acute leukemia working party of the EBMTJonathan Canaani, Myriam Labopin, Gerard Socié, et al.
American Journal of Hematology|April 9, 2021
Venetoclax combinations induce high response rates in newly diagnosed acute myeloid leukemia patients ineligible for intensive chemotherapy in routine practiceArie Apel, Yakir Moshe, Yishai Ofran, et al.
Biochemical Pharmacology|July 21, 2019
The mTOR inhibitor everolimus overcomes CXCR4-mediated resistance to histone deacetylase inhibitor panobinostat through inhibition of p21 and mitotic regulatorsKatia Beider, Hanna Bitner, Valeria Voevoda-Dimenshtein, et al.
European Journal of Haematology|May 31, 2023
Venetoclax-based salvage therapy for adult patients with relapsed/refractory acute lymphoblastic leukemiaJonathan Canaani, Avraham Frisch, Daniel A Pollyea, et al.
British Journal of Haematology|August 18, 2018
Minimal residual disease status predicts outcome of acute myeloid leukaemia patients undergoing T-cell replete haploidentical transplantation. An analysis from the Acute Leukaemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation (EBMT)Jonathan Canaani, Myriam Labopin, Xiao J Huang, et al.
Haematologica|March 4, 2017
Impact of ABO incompatibility on patients' outcome after haploidentical hematopoietic stem cell transplantation for acute myeloid leukemia - a report from the Acute Leukemia Working Party of the EBMTJonathan Canaani, Bipin N Savani, Myriam Labopin, et al.
Echocardiography (Mount Kisco, N.Y.)|November 10, 2019
Two-dimensional speckle-tracking strain detects subclinical cardiotoxicity in older patients treated for acute myeloid leukemiaGregory J Cascino, Woo Bin Voss, Jonathan Canaani, et al.
American Journal of Hematology|November 9, 2017
Donor age determines outcome in acute leukemia patients over 40 undergoing haploidentical hematopoietic cell transplantationJonathan Canaani, Bipin N Savani, Myriam Labopin, et al.
Leukemia|March 9, 2019
Prognostic significance of recurring chromosomal abnormalities in transplanted patients with acute myeloid leukemiaJonathan Canaani, Myriam Labopin, Maija Itälä-Remes, et al.
Acta Haematologica|September 12, 2024
Outcomes of Fedratinib in Routine Treatment of Ruxolitinib-Resistant or -Refractory Patients with Primary and Post-Polycythemia Vera or Essential Thrombocythemia Myelofibrosis: A Nationwide Retrospective StudyAdrian Duek, Alexandra Tzinman, Kira Maziuk, et al.
Pageof 6